Jazz Pharma (JAZZ) Unit Gets 'Markman Ruling' from U.S. Over Roxane Labs Patent Litigation
Go back to Jazz Pharma (JAZZ) Unit Gets 'Markman Ruling' from U.S. Over Roxane Labs Patent Litigation| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 245.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $245.85 | 52 Week High | $160.00 | |||
| Open | $245.85 | 52 Week Low | $95.80 | |||
| Day High | $245.85 | P/E | 45.70 | |||
| Day Low | $245.85 | EPS | $5.38 | |||
| Volume | 359 | |||||
